Trade Summary

Yesterday, Scharen-Guivel Hilda Frederique, serving as Dir at IRADIMED CORP (IRMD), sold 3,000 shares at $95.00 per share, for a total transaction value of $285,000.00. Following this transaction, Scharen-Guivel Hilda Frederique now holds 5,598 shares of IRMD.

This sale represents a 34.89% decrease in Scharen-Guivel Hilda Frederique's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 4:21 PM ET, meaning the disclosure happened on the same day as the trade.

IRADIMED CORP operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.